Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2015 Jun 26;29026:16372-82. doi: 10.1074/jbc.M114.622555.
Show Gene links
Show Anatomy links
Interaction of α-Lipoic Acid with the Human Na+/Multivitamin Transporter (hSMVT).
Zehnpfennig B
,
Wiriyasermkul P
,
Carlson DA
,
Quick M
.
???displayArticle.abstract???
The human Na(+)/multivitamin transporter (hSMVT) has been suggested to transport α-lipoic acid (LA), a potent antioxidant and anti-inflammatory agent used in therapeutic applications, e.g. in the treatment of diabetic neuropathy and Alzheimer disease. However, the molecular basis of the cellular delivery of LA and in particular the stereospecificity of the transport process are not well understood. Here, we expressed recombinant hSMVT in Pichia pastoris and used affinity chromatography to purify the detergent-solubilized protein followed by reconstitution of hSMVT in lipid bilayers. Using a combined approach encompassing radiolabeled LA transport and equilibrium binding studies in conjunction with the stabilized R-(+)- and S-(-)-enantiomers and the R,S-(+/-) racemic mixture of LA or lipoamide, we identified the biologically active form of LA, R-LA, to be the physiological substrate of hSMVT. Interaction of R-LA with hSMVT is strictly dependent on Na(+). Under equilibrium conditions, hSMVT can simultaneously bind ~2 molecules of R-LA in a biphasic binding isotherm with dissociation constants (Kd) of 0.9 and 7.4 μm. Transport of R-LA in the oocyte and reconstituted system is exclusively dependent on Na(+) and exhibits an affinity of ~3 μm. Measuring transport with known amounts of protein in proteoliposomes containing hSMVT in outside-out orientation yielded a catalytic turnover number (kcat) of about 1 s(-1), a value that is well in agreement with other Na(+)-coupled transporters. Our data suggest that hSMVT-mediated transport is highly specific for R-LA at our tested concentration range, a finding with wide ramifications for the use of LA in therapeutic applications.
Abramson,
Structure and function of Na(+)-symporters with inverted repeats.
2009, Pubmed
Abramson,
Structure and function of Na(+)-symporters with inverted repeats.
2009,
Pubmed
Balamurugan,
Biotin uptake by human intestinal and liver epithelial cells: role of the SMVT system.
2003,
Pubmed
Bast,
Lipoic acid: a multifunctional antioxidant.
2003,
Pubmed
Berkson,
Thioctic acid in treatment of hepatotoxic mushroom (Phalloides) poisoning.
1979,
Pubmed
Bharat,
Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy.
2002,
Pubmed
Breithaupt-Grögler,
Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data.
1999,
Pubmed
Bustamante,
Alpha-lipoic acid in liver metabolism and disease.
1998,
Pubmed
Carlson,
The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects.
2007,
Pubmed
Carreau,
Biosynthesis of lipoic acid via unsaturated fatty acids.
1979,
Pubmed
Eskandari,
Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity.
1997,
Pubmed
,
Xenbase
Faham,
The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport.
2008,
Pubmed
Foster,
Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy.
2007,
Pubmed
Harrison,
The metabolism of dl-(1,6-14C)lipoic acid in the rat.
1974,
Pubmed
Hediger,
The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction.
2004,
Pubmed
Jung,
Unidirectional reconstitution and characterization of purified Na+/proline transporter of Escherichia coli.
1998,
Pubmed
Korotchkina,
R-lipoic acid inhibits mammalian pyruvate dehydrogenase kinase.
2004,
Pubmed
Li,
Identification of a second substrate-binding site in solute-sodium symporters.
2015,
Pubmed
Licata,
Over-expression of a mammalian small conductance calcium-activated K+ channel in Pichia pastoris: effects of trafficking signals and subunit fusions.
2006,
Pubmed
Maczurek,
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
2008,
Pubmed
Malinauskaite,
A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters.
2014,
Pubmed
Milne,
Molecular structure of a 9-MDa icosahedral pyruvate dehydrogenase subcomplex containing the E2 and E3 enzymes using cryoelectron microscopy.
2006,
Pubmed
Nasr,
Radioligand binding to nanodisc-reconstituted membrane transporters assessed by the scintillation proximity assay.
2014,
Pubmed
Packer,
alpha-Lipoic acid as a biological antioxidant.
1995,
Pubmed
Packer,
Neuroprotection by the metabolic antioxidant alpha-lipoic acid.
1997,
Pubmed
Portulano,
The Na+/I- symporter (NIS): mechanism and medical impact.
2014,
Pubmed
Quick,
Neutralization of a conserved amino acid residue in the human Na+/glucose transporter (hSGLT1) generates a glucose-gated H+ channel.
2001,
Pubmed
,
Xenbase
Quick,
Employing Escherichia coli to functionally express, purify, and characterize a human transporter.
2002,
Pubmed
Quick,
Monitoring the function of membrane transport proteins in detergent-solubilized form.
2007,
Pubmed
Reed,
A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes.
2001,
Pubmed
Saier,
A functional-phylogenetic classification system for transmembrane solute transporters.
2000,
Pubmed
Schaffner,
A rapid, sensitive, and specific method for the determination of protein in dilute solution.
1973,
Pubmed
Schreibelt,
Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity.
2006,
Pubmed
Shay,
Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.
2009,
Pubmed
Shi,
The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site.
2008,
Pubmed
Smith,
Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress.
2004,
Pubmed
Sonders,
Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants.
1997,
Pubmed
,
Xenbase
Subramanian,
Membrane targeting and intracellular trafficking of the human sodium-dependent multivitamin transporter in polarized epithelial cells.
2009,
Pubmed
Takaishi,
Transepithelial transport of alpha-lipoic acid across human intestinal Caco-2 cell monolayers.
2007,
Pubmed
Tang,
Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy.
2007,
Pubmed
Vincent,
Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study.
2007,
Pubmed
Wang,
Human placental Na+-dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal localization.
1999,
Pubmed
,
Xenbase
Watanabe,
The mechanism of sodium and substrate release from the binding pocket of vSGLT.
2010,
Pubmed
Wright,
Biology of human sodium glucose transporters.
2011,
Pubmed
Yamashita,
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters.
2005,
Pubmed
Zehnpfennig,
Functional reconstitution of human ABCC3 into proteoliposomes reveals a transport mechanism with positive cooperativity.
2009,
Pubmed
Zhao,
Assembly of the covalent linkage between lipoic acid and its cognate enzymes.
2003,
Pubmed
Zhao,
Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue.
2011,
Pubmed
Zimmer,
Dose/response curves of lipoic acid R-and S-forms in the working rat heart during reoxygenation: superiority of the R-enantiomer in enhancement of aortic flow.
1995,
Pubmed
de Carvalho,
Surprising substrate versatility in SLC5A6: Na+-coupled I- transport by the human Na+/multivitamin transporter (hSMVT).
2011,
Pubmed
,
Xenbase
